Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Clinical trial NCT00895466 · UNKNOWN
Trial details
- NCT number
- NCT00895466
- Sponsor
- Pepscan Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.